i am really trying to get my head around it aswell.
I've been trying to go though this paper on the phase 1,2 trial of 591. https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.32072
its so hard to figure out why the OS is so good, because the other metrics don't look amazing, yet 591 has more than double the survival benefit of pluvicto, which is the number one stat for cancer drug.
I don't no if I'm wrong but in the paragraph named ""antitumor effect and survival"" , they mention the below,
The time to progression ranged from 7 to 81.3 weeks, with a median time to progression of 16.7 weeks (95% confidence interval [CI], 14.4-21).
I'm assuming this is PFS? if it is the numbers still don't look amazing. Yet we get amazing OS
but the trial involves a lot of low dose patients, so that would skew the data for the time progression above.
- Forums
- ASX - By Stock
- TLX
- Understanding Telix
Understanding Telix, page-731
-
- There are more pages in this discussion • 845 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TLX (ASX) to my watchlist
(20min delay)
|
|||||
Last
$20.48 |
Change
0.030(0.15%) |
Mkt cap ! $6.854B |
Open | High | Low | Value | Volume |
$20.35 | $20.83 | $20.30 | $10.68M | 520.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1586 | $20.48 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.58 | 898 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 387 | 20.410 |
1 | 196 | 20.400 |
1 | 2 | 20.300 |
1 | 1000 | 20.290 |
1 | 300 | 20.160 |
Price($) | Vol. | No. |
---|---|---|
20.700 | 4500 | 1 |
20.750 | 500 | 1 |
20.800 | 1792 | 2 |
20.880 | 1784 | 2 |
20.890 | 3000 | 1 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
NEWS
Antler Copper Project hits major permitting milestone – air quality permit advances to final review
CC9
Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity
TLX (ASX) Chart |